Prognostic relevance of large-platelet counts in patients with immune thrombocytopenic purpura

Haematologica

Volumn 90, Issue 12, 2005, Pages 1715-1716

  Michel, Marc ^a,c   Kreidel, Felix ^a   Chapman, E Sabrinah ^b   Zelmanovic, David ^b   Bussel, James B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BAYER CORPORATION   (United States)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

ADVIA 120; Immune thrombocytopenic purpura; Large platelets; Mean platelet volume (MPV); Platelet production

Indexed keywords

IMMUNOGLOBULIN; RHESUS D ANTIBODY;

ADOLESCENT; ADULT; AGED; ANALYZER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LINEAR REGRESSION ANALYSIS; PREDICTION; PROGNOSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; CELL SIZE; CHILD; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET COUNT; PROGNOSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY;

EID: 29144449867     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bussel JB. Fc receptor blockade and immune thrombocytopenic purpura. Sem Hematol 2000;37:261-8.
2. Kunicka JE, Fischer G, Murphy J, Zelmanovic D. Improved platelet counting using two-dimensional laser light scatter. Am J Clin Pathol 2000;114:283-9.
3. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practical guideline developed by explicit methods of the American Society of Hematology. Blood 1996;86:3-40.
4. Takubo T, Yamane T, Hino M, Ohta K, Koh KR, Tatsumi N. Clinical significance of simultaneous measurement of reticulated platelets and large platelets in idiopathic thrombocytopenic purpura. Haematologica 2000;30:183-92.
5. Koh KR, Yamane T, Ohta K, Hino M, Takubo T, Tatsumi N. Pathophysiological significance of simultaneous measurement of reticulated platelets, large platelets and serum thrombopoietin in non-neoplastic thrombocytopenic disorders. Eur J Hematol 1999;65:295-301.
6. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-55.
7. Coopamah MD, Freedman J, Semple JW. Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist. Blood 2003;102:2862-7.
8. Beer JH, Buchi L, Steiner B. Glycocalicin: a new assay, the normal plasma levels and its potential usefulness in selected diseases. Blood 1994;83:691-702.
9. Porcelijn L, Folman CC, Bossers B, Huiskes E, Overbeeke MA, van der Schoot CE, et al. The diagnostic value of thrombopoietin level measurements in thrombocytopenia. Thromb Haemost 1998;79:1101-5.
10. Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IFF) in peripheral thrombocytopenia. Br J Haematol 2004;126:93-9.